Skip to main content

Quality accreditation

TDL participates in recognised National External Quality Assessment Schemes. These schemes are subscribed to by NHS and private laboratories. Results are subjected to strict internal and external quality control.

UKNEQAS, WEQAS, RIQAS, BIOARD

ACE

AFP / CEA & HCG

Antibiotics (Gentamicin, Vancomycin and Amikacin)

Anti-Hbs Detection

Ammonia

Autoimmune (RF and TPO)

B2 Microglobulin

Cardiac Markers

Clinical Chemistry

CMV IgG / IgM

CRP & Ultra-Sensitive CRP

CSF

Cyclosporin and Tacrolimus

DEQAS

Diagnostic Serology Exanthem

Diagnostic Serology Hepatitis

Drugs of Abuse

Ethanol

Faecal Markers for Inflammation (Calprotectin)

Free Beta HCG and PAPP-A

GFR

Glucose / Glucometer

Glycated Haemoglobins

Guildford Peptides

Haematinics

Healthcontrol Therapeutic Drugs Screen (TDM)

Hepatitis A (with B and C)

Hepatitis B Serology 

Hepatitis C Serology

HIV Serology

Homocysteine

HTLV

IGF-1

Immunity Screen

Lipase

Lipid Investigations

NT-Pro BNP

Paediatric Bilirubins

Parasitology

Peptide Hormones

PSA, Free PSA

PTH, ACTH and hCT

Rubella IgG Serology

Salicylate and Paracetamol

Specific Proteins

Steroid Hormones

Syphilis Serology

Thyroglobulin Surveys

Thyroid Hormones

Total IgE

Toxoplasma IgG / M Serology

Tumour Markers

Toxoplasma IgM Serology

Toxoplasma IgG Serology

Trace Elements

Urine Chemistry

Vitamin D (25 OH)

UKNEQAS

Automated Differential Leucocyte Count

Blood Film Morphology

Coagulation (Including PoCT Coagulation)

EBV Mononucleosis

ESR and NRBC (nucleated Rbc)

Flow Cytometry 

  • Leukaemia immunophenotyping
  • Myeloperoxidase
  • Iron stain

Full Blood Count

Haematology

Haematology Analysis

Malaria

Parasite Films

Reticulocyte

Sickle Screening

Thrombophilia Screening

Blood Transfusion Laboratory Practice Scheme (BTLP)

Special Coagulation

Von Willebrand (vWD) screen

Anti-Xa assays

Plasma viscosities

ADAMTS-13 activity

ADAMTS-13 antibody

Heparin / Platelet Factor 4 Induced Antibodies

Platelet function analysis (RCPA)

Lupus anticoagulant:

  • Taipan Venom Time
  • DRVVT assay

Molecular genetics

Acquired array (CLL/MDS)  

Acute Lymphoblastic Leukaemia (ALL) – G banding and FISH  

BCR ABL1 and AML Translocation Identification 

BCR ABL1 Kinase Domain Variant 

BCR ABL1 Major Quantification 

BCR ABL1 Minor Quantification 

BoBs Rapid Aneuploidy detection  

BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia 

Chlamydia & Gonorrhoea detection by PCR  

Chronic Lymphocytic Leukaemia (CLL) 

Constitutional Clinical Cytogenetics (Rounds for Amniocentesis, CVS, Solid Tissue, Blood, Array CGH)  

Cystic Fibrosis  

Duchenne/Becker Muscular Dystrophy  

FLT3 Mutation Status 

Haematological Technical FISH 

Hereditary Haemochromotosis (C282Y+H63D) genotyping + reporting  

HLA Class I (HLA-A, HLA-B, HLA-C) Tissue Typing (low resolution)  

HLA Class II (HLA-DRB1, HLA-DQB1) Tissue Typing (low resolution)   

HLA-B27 Genotyping  

HLA-B57*01 Genotyping  

HLA+ Disease Typing Cytochrome P450 2C19 genotyping  

Human Papillomavirus DNA  

IG/TCR Clonality Status 

IGHV for CLL 

Inborn Errors of Metabolism 

JAK2 p.Val617Phe (V617F) Mutation Status 

KIT p.Asp816Val (D816V) Mutation Status for Mast Cell Disease 

Lymphoid Gene Panels 

Lymphoma 

Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinaemia 

Measurable Residual Disease for AML by Molecular Methods 

Myeloid (AML/MDS/CML) – G-banding and FISH 

Myeloid Gene Panels 

Myeloma – sample FISH set up and analysis plus online  

Myeloproliferative Neoplasms Diagnostic Testing 

NGS AML gene panel  

NGS Myeloid Target Panel 

NIPT for aneuploidies and sexing  

NMP1 Mutation Status 

Paediatric Acute Leukaemia Translocations 

Paternity Testing  

Prader-Willi and Angelman Syndromes 

QF-PCR Aneuploidy Detection  

Sexually Transmitted Diseases (CT/NG/MGEN/TV/UU/UP)  

Spinal Muscular Atrophy  

Thrombophilia (Factor II, V, MTHFR)  

TP53 for CLL 

Y Microdeletion PCR Assay

 

Molecular virology

Adenovirus DNA Viral load  

Bacterial 16S  

B19 virus DNA Viral load  

BK virus DNA Viral load  

CMV DBS (dried blood spots)  

CMV DNA Plasma Viral load  

CMV DNA Whole Blood Viral load  

CMV Resistance  

EBV DNA Plasma Viral load  

EBV DNA Whole Blood Viral load  

Enterovirus RNA  

Gastroenteritis Virus Panel  

Hepatitis B Genotyping  

Hepatitis B Drug Resistance Typing  

Hepatitis B Viral Load  

Hepatitis C genotyping  

Hepatitis C Resistance genome detection (NS5a & b)  

Hepatitis C Resistance Typing (NS3 & NS5a)  

Hepatitis C Viral Load  

Hepatitis D Virus Viral load and Qualitative PCR  

Hepatitis E Virus Viral load and Qualitative PCR 

HIV-1 Drug Resistance (Pol)  

HIV-1 Drug Resistance (Integrase) 

HIV-1 RNA Viral load and Qualitative PCR 

HIV-1 DNA Genome Detection  

HIV-1 Tropism Genome Detection  

HSV 1&2 DNA 

HSV 1&2 DNA HSV Drug Resistance  

Human Herpes virus 6 DNA 

Influenza Haemagglutinin typing  

JC virus DNA 

Measles and Mumps PCR  

MERS Coronavirus 

Parechovirus RNA  

Respiratory panel I  

Respiratory panel II  

SARS-CoV-2 (COVID-19) PCR/NAAT 

SARS-CoV-2 Variants of Concern (VOC) sequencing 

Syphilis PCR  

Transplantation Virus Panel  

VZV DNA 

Laboratory Quality Scheme

Helicobacter pylori antigen from faeces

Polarising crystal microscopy from synovial fluid

Streptococcus pyogenes (Group A) detection in pharyngeal samples

Surveillance for multi drug resistant bacteria

Blood culture and gram stain

Candida PCR

Mycoplasma PCR

Aspergillus PCR

 

UKNEQAS

Clostridium difficile detection and toxin testing

Faecal parasites

General bacteriology

Genital pathogens

MRSA screening

Microbial susceptibilities

Mycobacterial microscopy

Mycobacterial culture and molecular detection

Antifungal assays

Antifungal susceptibilities

Cryptococcal antigen

Fungal culture

Fungal biomarkers

Urinary antigen

 

WEQAS POCT

Urinalysis

 

QCMD

Dermatophyte PCR

PCP PCR

Atypical pneumoniae PCR

UKNEQAS: General Immunology

Allergen Component Testing

Autoimmune Serology ANCA/GBM Antibodies

Bullous Dermatosis Antibodies

Allergen Specific IgE Antibodies

General Autoimmune Serology

Anti-Phospholipid Antibodies (B2GP)

Nuclear and Related Antigens

IGRA (Interferon gamma release assay)

Intrinsic Factor Antibodies

Diabetic Marker (Islet Cell Antibodies)

Myositis Associated Antibodies

Specific Microbial Antibodies

C1 Esterase inhibitor and functional complement

Syphilis (TPPA and RPR)

Lyme (IgG + IgM)

Hepatitis C

Hepatitis E (IgG and IgM)

Coeliac Disease (Endomysium, Tissue transglutaminase)

Triptase

UKNEQAS: Infectious Immunology

HIV Serology / POCT

Immunity Screen – VZV, Parvo Viruse, EBV

Chlamydia Detect

Varicella Zoster (IgG) Serology

Parasite Serology

Chlamydia & Gonorrhoea (NAAT / PCR)

Hepatitis E

RIQAS Scheme

Procalcitonin

 

RCPAQAP Scheme

Legionella (IgG) Serology

Striated Muscle Antibodies

Chlamydia Serology

 

INSTAND Scheme

Adrenal Antibodies

Hepatitis E Serology

RNAP Antibodies

 

CSCQ Scheme

Lyme Borrelia Serology

 

Laboratory Quality Scheme

Herpes Simplex 1 & 2 Antibodies

Cytomegalovirus Antibodies

Antistreptolysin O Titre

Helicobacter Pylori IgG Antibodies

RNA Polymerase III

Euroimmun ifQ-Lubeck (Liver) Autoimmune Disease Scheme

UKNEQAS

Steroid Hormones

Peptide Schemes 1 to 4

Thyroid Scheme

Allergens Scheme

SHBG

Prostate Specific Antigen

Tumour Markers

PTH

Specific IgE / Total IgE

AFP / CEA

PHE

Gynaecological Cytopathology EQA Scheme (GEQA)

National EQA Scheme for the Preparation and Staining
of Cervical Liquid Based Cytology Samples (TEQA)

HOLOGIC

ThinPrep Stain EQA

UKNEQAS for Microbiology

Molecular Detection of HPV

HIV Serology

UKNEQAS for CPT

Stained Non-Gynaecological Cytology Module.

All non-gynaecological (diagnostic cytology), including Urine Cytology, are referred to a UKAS accredited laboratory for reporting.

 

UKNEQAS

Semen Analysis Scheme

Accredited by British Standards Institute ISO/IEC 27001:2013

ISO 14001:2015

ISO 15189:2012 

Links to the UKAS schedules of accreditation (in PDF format)

(Certain UKAS accreditations can be found under Health Services Laboratories (HSL), which is part of the TDL Group of Laboratories.)

HSL Blood Sciences (8169)

HSL Infection Sciences (8860)

HSL Molecular Pathology and Genetics (8059)

TDL Manchester (8812)

TDL Andrology (10199)

HSL Cytology (8511)

TDL Urine Cytology (9706)

CQC Reports

TDL is monitored by the Care Quality Commission, the independent regulator of health and social care in England.

You can find out details of their inspection summaries using the links below:

 

The Doctors Laboratory, The Halo Building

https://www.cqc.org.uk/location/1-5588555895

 

The Doctors Laboratory, Patient Reception, 76 Wimpole Street

https://www.cqc.org.uk/location/1-2166893538